N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials.
about
What do we currently know about metabolic syndrome and atrial fibrillation?Emerging nutrition science on fatty acids and cardiovascular disease: nutritionists' perspectivesEfficacy of a unique omega-3 formulation on the correction of nutritional deficiency and its effects on cardiovascular disease risk factors in a randomized controlled VASCAZEN(®) REVEAL Trial.Effect of omega-three polyunsaturated fatty acids on inflammation, oxidative stress, and recurrence of atrial fibrillation.Alternative medicine in atrial fibrillation treatment-Yoga, acupuncture, biofeedback and more.Upstream Treatment of Atrial Fibrillation with n-3 Polyunsaturated Fatty Acids: Myth or Reality?Plasma phospholipid omega-3 fatty acids and incidence of postoperative atrial fibrillation in the OPERA trial.Omega-3 fatty acids and cardiovascular disease: new developments and applications.N-3 fatty acids for prevention of cardiovascular disease.Omega-3 polyunsaturated fatty acids and cardiovascular disease: an emphasis on omega-3-acid ethyl esters 90 for the treatment of hypertriglyceridemia.Pharmacological strategies for prevention of postoperative atrial fibrillation.Omega-3 polyunsaturated fatty acids for cardiovascular diseases: present, past and future.Serum Fatty Acids, Traditional Risk Factors, and Comorbidity as Related to Myocardial Injury in an Elderly Population with Acute Myocardial Infarction.Omega-3 fatty acids do not alter P-wave parameters in electrocardiogram or expression of atrial connexins in patients undergoing coronary artery bypass surgery.DietaryFish and Long-Chain n-3 Polyunsaturated Fatty Acids Intake and Risk of Atrial Fibrillation: A Meta-Analysis.Omega-3 Index and Anti-Arrhythmic Potential of Omega-3 PUFAs.A meta-analysis on Omega-3 supplements in preventing recurrence of atrial fibrillation.Dyslipidaemia in the elderly: to treat or not to treat?
P2860
Q26864437-08094057-F745-49E5-B20A-F3E168612146Q28080910-E142B7B2-F1C4-45B6-A67A-FD2D9DFBDEAEQ34250605-F917743E-1FE8-4EA4-AC34-46C2B93F6CDFQ34771487-24C337A5-C825-492C-B2A9-9743C2EBE80EQ35062038-28072DEF-6A30-4AC0-8142-C5C68265B3FAQ36518152-92D77C44-DB9A-469D-817E-D9CA4E130F05Q37328824-F369CEF7-23EC-4D44-9018-58D3EE87EEF4Q38160641-640763CE-22C4-4FC2-B6D3-A6542A5338F7Q38248569-B7B36047-E6AC-462B-8826-24C47B776111Q38260532-1832625F-C575-4022-A6AE-B1852D235451Q38361941-0F86AB07-622F-4A17-BFB4-7E5E63176EE9Q38680756-6CF69608-AE42-485B-B1C4-330E2F94491EQ38738765-D0CEBB56-FB85-4B90-84D4-3699630C7202Q40018992-FB84731A-93AF-4F91-8BE8-6BFAE1734F8BQ40066783-D113A61D-CAF3-4D23-85C1-902B9EFE2DDFQ42517703-F7D1DC3D-191F-4F4F-B24F-B183B54B9051Q50042964-ABED1BFA-A550-4C79-8450-A89DAB2E20B8Q50180407-5D7359C0-646C-451C-9DDD-36C8BC981E60
P2860
N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
N-3 polyunsaturated fatty acid ...... randomized controlled trials.
@ast
N-3 polyunsaturated fatty acid ...... randomized controlled trials.
@en
type
label
N-3 polyunsaturated fatty acid ...... randomized controlled trials.
@ast
N-3 polyunsaturated fatty acid ...... randomized controlled trials.
@en
prefLabel
N-3 polyunsaturated fatty acid ...... randomized controlled trials.
@ast
N-3 polyunsaturated fatty acid ...... randomized controlled trials.
@en
P2093
P2860
P31
P921
P356
P1476
N-3 polyunsaturated fatty acid ...... randomized controlled trials.
@en
P2093
Alejandro Macchia
Daniel Ferrante
Daniel Nul
Gianni Tognoni
Hernán C Doval
Hugo Grancelli
Javier Mariani
Sergio Varini
P2860
P304
P356
10.1161/JAHA.112.005033
P5008
P577
2013-02-19T00:00:00Z